Authors: Stengard, JH Salomaa, V Rasi, V Vahtera, E Ehnholm, C Krusius, T Perola, M Vartiainen, E

Citation: Jh. Stengard et al., Utility of the Arg/Gln polymorphism of the factor VII (FVII) gene, serum lipid levels and body mass index in the prediction of the FVII : C and FVII : Ag in North Karelia; a cross-sectional and prospective study, BL COAG FIB, 12(6), 2001, pp. 445-452

Authors: Rissanen, P Vahtera, E Krusius, T Uusitupa, M Rissanen, A

Citation: P. Rissanen et al., Weight change and blood coagulability and fibrinolysis in healthy obese women, INT J OBES, 25(2), 2001, pp. 212-218

Authors: Jousilahti, P Salomaa, V Rasi, V Vahtera, E Palosuo, T

Citation: P. Jousilahti et al., The association of c-reactive protein, serum amyloid a and fibrinogen withprevalent coronary heart disease - baseline findings of the PAIS project, ATHEROSCLER, 156(2), 2001, pp. 451-456

Authors: Levo, A Kuismanen, K Holopainen, P Vahtera, E Rasi, V Krusius, T Partanen, J

Citation: A. Levo et al., Single founder mutation (W380G) in type II protein C deficiency in Finland, THROMB HAEM, 84(3), 2000, pp. 424-428

Authors: Kekomaki, R Rasi, V Ebeling, F Vahtera, E Javela, K Koski, T Myllyla, G Ikkala, E

Citation: R. Kekomaki et al., von Willebrand disease in Finland, HAEMOPHILIA, 5, 1999, pp. 72-74

Authors: Jousilahti, P Salomaa, V Rasi, V Vahtera, E

Citation: P. Jousilahti et al., Symptoms of chronic bronchitis, haemostatic factors, and coronary heart disease risk, ATHEROSCLER, 142(2), 1999, pp. 403-407